Skip to content
  • Spain
  • United Kingdom
  • Europe
  • United States
  • Japan
  • The Middle East
  • Brazil
  • Italy
  • Canada
  • India
  • China
  • Taiwan
  • Mexico
  • Perú
  • Russia
  • Chile
  • Argentina
  • Turkey
  • UK
  • 02080688176 Request Information
  • 02080688176 Request Information
United KingdomUnited Kingdom
  • We guide you
    • Fertility
    • Prevent inherited diseases
    • Worry-free pregnancy
  • Our Services
    • For Health Specialists
    • For Patients
  • About us
    • Research & Igenomix Foundation
    • About Igenomix
  • COVID-19 Webinars
  • Registered users
Genetic Solutions > EndomeTRIO

EndomeTRIO: The endometrium matters

A new dimension of endometrial health to improve the reproductive prognosis of your patients.

  • Technical Overview
  • Scientific evidence
  • I’m not a health specialist

EMMA + ALICE + ERA

A better understanding of endometrial health to improve reproductive prognoses

20% of infertility is caused by
the endometrial factor.

Are you interested?

Request information
Or Email us at info.uk@igenomix.com
Overview
  • EndomeTRIO
  • Benefits
  • Indications

What test does the EndomeTRIO analysis include?

ERA

The ERA test evaluates the receptivity of the endometrium to determine if, at the time of biopsy, the uterine lining is receptive to embryo implantation. This information allows us to determine the ideal time for a personalised embryo transfer (pET). The ERA test resulted in a 73% pregnancy rate in patients with implantation failure.

More info

ALICE

ALICE (Analysis of Infectious Chronic Endometritis) is a diagnostic test to detect the bacteria causing chronic endometritis (CE), a condition that is associated with infertility.
Independent studies show that this condition affects up to 30% of infertile patients, and in cases of repeated implantation failure or recurrent pregnancy loss, this can rise to 66%*.
ALICE identifies the most common bacteria causing CE and helps clinicians to recommend appropriate antibiotic and probiotic treatments.

More info

EMMA

EMMA (Endometrial Microbiome Metagenomic Analysis) is a screening test to evaluate the endometrium at the microbiological level, improving clinical management of infertile patients.
By analysing the endometrial microbiome, EMMA determines whether the uterine microbial environment is optimal for embryo implantation.
EMMA provides information about the ten most abundant bacteria in the endometrium, recommending embryo transfer or appropriate treatment, depending on results.

More info

What is the procedure?

Why does the endometrium matter?

The endometrium has been noted as a key factor for a healthy pregnancy in recent scientific studies. In fact, 20% of infertility is caused by the endometrial factor.

Since 2014, Igenomix has been conducting a deep line of research to understand the role of the endometrial factor in recurrent implantation failure patients.

Our recent publications in the American Journal of Obstetrics and Gynecology (AJOG) demonstrate a new dimension of endometrial health that can improve your patient’s reproductive prognosis.

Why use endomeTRIO test?

  • A better understanding of endometrial health to improve your patient’s reproductive prognosis:  Analyses Endometrial receptivity, chronic endometritis and endometrial flora.
  • EndomeTRIO uses the latest Next Generation Sequencing technology.

Who should use EndomeTRIO Analysis?

  • Women who have experienced implantation failure with morphologically good quality embryos
  • Women with a history of recurrent pregnancy loss
  • Women with a morphologically normal uterus and normal endometrial thickness (≥ 6 mm), where the physical features of the uterus and endometrium are unlikely to be the problem
  • Women with Chronic Endometritis

Methodology:

Only a single endometrial biopsy is needed to perform the combined ERA+EMMA+ALICE test, EndomeTRIO.

How should I and send the sample?

An endometrial biopsy taken from the uterine fundus must be immediately place into an ERA cryotube, shaken and stored in a refrigerator (4-8°C/ 39-46°F) for at least 4 hours.
Samples are sent at room temperature(<35ºC/95ºF) accompanied with the patient´s informed consent and a completed requisition form.

Test Limitations

  • Patients planning an assisted reproduction treatment
  • ERA test limitations
  • EMMA test limitations
  • ALICE test limitations
Documentation
  • Specialists’ documents

Clinical Sheets

Download

Brochure

Download

EndomeTRIO Manual

Download
Scientific evidence

Relevant related studies:

Cicinelli et al. Reprod Sci 2014; 21(5):640-7.

Cicinelli et al. Hum Reprod. 2015; 30(2):323-30. 

Moreno I. et tal. Am J Obstet Gynecol, 2018, 218(6):602-602.

Moreno I. et tal. Am J Obstet Gynecol. 2016;215(6):684-703.

Igenomix and fertility

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility specialists worldwide, we investigate human reproduction to change the lives of those who are trying to conceive.

Learn more about Igenomix

Other services

ERA

Evaluates the endometrial receptivity

More information

EMMA

Evaluates the endometrium at the microbiological level

More information

ALICE

Detects the bacteria causing chronic endometritis

More information

Igenomix is in the media

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

No. 10131

Click to view our ISO: 15189 accreditation

OUR SERVICES

Genetic solutions
For patients
Learn about genetics
Sending Samples and Documentation

ABOUT US

About Igenomix
Contact
User Manual
Quality
Work with us

FOLLOW IGENOMIX

  02080688176
  Write us
  • Spain
  • United Kingdom
  • Europe
  • United States
  • Japan
  • The Middle East
  • Brazil
  • Italy
  • Canada
  • India
  • China
  • Taiwan
  • Mexico
  • Perú
  • Russia
  • Chile
  • Argentina
  • Turkey
Language

[2019] © Igenomix Privacy policy Quality policy Legal note Cookies policy       User feedback     Complaints Form

Request Information


  • reCAPTCHA demo: Simple page

  • We guide you
    • Fertility
    • Prevent inherited diseases
    • Worry-free pregnancy
  • Our Services
    • For Health Specialists
    • For Patients
  • About us
    • Research & Igenomix Foundation
    • About Igenomix
  • COVID-19 Webinars
  • UK
  • Registered users
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok